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Abstract
The influenza virus copies its genomic RNA in the nuclei of host cells, but the viral particles are formed at the plasma membrane. Thus,
the export of new genome from the nucleus into the cytoplasm is essential for viral production. Several viral proteins, such as nucleoprotein
(NP) and RNA polymerases, synthesized in the cytoplasm, are imported into the nucleus, and form viral ribonucleoprotein (vRNP) with new
genomic RNA. vRNP is then exported into the cytoplasm from the nucleus to produce new viral particles. M1, a viral matrix protein, is
suggested to participate in the nuclear export of vRNP. It was found unexpectedly that the production of influenza virus was suppressed in
MDCK cells at 41°C, although viral proteins were synthesized and the cytopathic effect was observed in host cells. Indirect immunoflu-
orescent staining with anti-NP or M1 monoclonal antibody showed that NP and M1 remained in the nuclei of infected cells at 41°C,
suggesting that a suppression of viral production was caused by inhibition of the nuclear export of these proteins. The cellular machinery
for nuclear export depending on CRM1, which mediates the nuclear export of influenza viral RNP, functioned normally at 41°C.
Glycerol-density gradient centrifugation demonstrated that vRNP also formed normally at 41°C. However, an examination of the interaction
between vRNP and M1 by immunoprecipitation indicated that M1 did not associate with vRNP at 41°C, suggesting that the association is
essential for the nuclear export of vRNP. Furthermore, when infected cells incubated at 41°C were cultured at 37°C, the interaction between
vRNP and M1 was no longer detected even at 37°C. The results suggest that M1 synthesized at 41°C is unable to interact with vRNP and
the dissociation of M1 from vRNP is one of the reasons that the transfer of vRNP into the cytoplasm from the nucleus is prevented at 41°C.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
We studied the mechanism of membrane fusion, using
experimental models of enveloped viral infection and skel-
etal myoblast differentiation. In the life cycle of an envel-
oped virus, both viral penetration and budding are associ-
ated with membrane fusion (Kielian and Jungerwirth, 1990;
Cadd et al., 1997). Also, on the differentiation of skeletal
myoblasts, mononucleated myoblasts fuse with each other
into multinucleated myotubes (Knudsen and Horwitz,
1977). The study of these fusion mechanisms is important
for understanding the biological functions of cell mem-
brane.
To analyze the mechanism of myoblast fusion, we have
been using quail myoblasts transformed with a temperature-
sensitive mutant of the Rous sarcoma virus (RSV), named
QM-RSV (Kim et al., 1992a, b). Cell differentiation in the
QM-RSV system is simply regulated by a change of culture
temperature. The cells proliferate at 35.5°C, a permissive
temperature for RSV, but do not differentiate. The cells
begin to differentiate at 41°C, a nonpermissive temperature
for RSV, and form myotubes through myoblast fusion. As
part of our investigation, the artificial myotubes were made
via the fusion of presumptive myoblasts using HVJ (Sendai
virus) and compared with spontaneous myotubes formed at
41°C (Saiuchi et al., 1993; Kim et al., 1995; Hirayama et al.,
2001).
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In the course of characterizing the artificial myotubes
from QM-RSV cells, we found unexpectedly that the pro-
duction of HVJ was markedly suppressed at 41°C, despite
that it was normal at 35.5°C. Thus, we examined the tem-
perature-dependency of viral production with other kinds of
virus. As a result, the production of the measles virus,
influenza virus, herpes simplex virus type-1, and poliovirus
was also found to be suppressed at 41°C. However, the
inhibitory mechanism of viral production appeared to differ
for each virus. For example, in the case of HVJ, the syn-
thesis of viral-specific proteins in host cells was inhibited at
41°C at the level of transcription (Ishida et al., 2002). On
the other hand, influenza viral proteins were synthesized
even at 41°C. However, our experiments showed that the
influenza viral proteins could not be exported from the
nucleus into the cytoplasm in host cells at 41°C.
The influenza virus is a RNA virus with an envelope.
Viral RNA is always found in association with viral
polypeptides, including the three subunits of RNA-depen-
dent RNA polymerases (PB1, PB2, and PA) and the viral
nucleoprotein (NP), to form viral ribonucleoprotein (vRNP)
complexes. After the influenza virus has invaded a host cell,
vRNP is released into the cytoplasm and enters the nucleus
via the cellular nuclear import pathway mediated by impor-
tin / (Martin and Helenius, 1991b; O’Neill et al., 1995).
In the nucleus, vRNP acts as a template for the synthesis of
mRNA and progeny genomic RNA. The mRNA for viral
proteins is exported into the cytoplasm and translated. Sev-
eral viral proteins, such as NP and RNA polymerases, are
imported into the nucleus and assembled together with
newly synthesized genomic RNA into vRNP in the nucleus.
The vRNP is then transferred into the cytoplasm via the
cellular CRM1-mediated nuclear export pathway to form
progeny viral particles with other viral components at the
plasma membrane (Elton et al., 2001; Ma et al., 2001;
Neumann et al., 2000). Thus, the export of vRNP from the
nucleus is one of the most important events in the infectious
cycle of the influenza virus (Lamb and Krug, 1996). Current
reports suggest that two viral proteins, matrix protein (M1)
and nuclear export protein (NEP/NS2) mediate the export of
vRNP via formation of a vRNP-M1-NEP/NS2 complex
(O’Neill et al., 1998; Neumann et al., 2000), but little is
known about its mechanism. The investigation of this pro-
cess is important for understanding not only the infectious
cycle of the influenza virus but also the cellular nuclear
transport system.
We investigated the inhibitory mechanism of influenza
viral production at 41°C associated with nuclear export of
viral proteins. It was clarified that the association of M1 is
essential to the export of vRNP from the nucleus to cyto-
plasm.
Results
Inhibition of viral production at 41°C
To investigate the effects of incubation temperature on the
production of influenza virus, MDCK cells were cultured at
37°C or 41°C after infection with A/Aichi/2/68/H3N2. Culture
fluids were harvested at various time points after the infection
and hemaggulutinating activity (HA) was assayed as viral
production. The results were plotted as hemaggultination units
(HAu/ml) (Fig. 1A). At 37°C, HA increased from 6-h incuba-
Fig. 1. Production of influenza virus at 37°C or 41°C. (A) MDCK cells were infected with influenza virus (A/Aichi/2/68/H3N2) and incubated at 37°C (E)
or 41°C (F). After the infection, culture fluids were harvested when indicated and viral production was assayed in hemagglutination units (HAu/ml). Viral
production at 41°C was almost undetectable. (B) Phase-contrast micrographs of infected cells cultured at 37°C (a) or 41°C (b) for 24 h. The cytopathic effect
of the infection was observed even at 41°C. Bar, 50 m.
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tion to about 600 HAu/ml within 24 h. After that, viral pro-
duction reached a plateau. In contrast to this, when the infected
cells were incubated at 41°C, the viral production was almost
undetectable. The cytopathic effect, however, was seen at 41°C
as well as 37°C (Fig. 1B). Similar results were obtained using
other influenza viral strains, A/PR/8/34/H1N1 and A/Okuda/
57/H2N2. These results imply that viral infection proceeded in
host cells, but some steps of viral production were inhibited at
41°C.
Synthesis of viral-specific proteins is not inhibited at
41°C
To examine which steps of viral production were inhib-
ited at 41°C, the synthesis of viral-specific proteins was
monitored. Infected cells incubated at 37°C or 41°C were
lysed, and viral-specific proteins were detected by immu-
noblotting using anti-influenza virus serum. As shown in
Fig. 2, viral proteins were detected from about 4 h after
infection and increased with incubation time at both tem-
peratures, although some nonspecific bands were recog-
nized between NP and M1 bands at 37°C and amounts of
viral proteins showed a slight reduction at 41°C.
For a more precise analysis, infected cells were pulse-
labeled with [35S]methionine from 5 to 6 h after infection,
when the synthesis of viral proteins had definitely started.
The proteins were separated by SDS–PAGE and the quan-
tity of radioactive viral proteins at 41°C was compared with
that at 37°C using a BAS-2000 system (Fuji Film Co. Ltd.).
Viral proteins were basically synthesized at both tempera-
tures, although the amounts showed a slight reduction at
41°C (data not shown).
Inhibition of the export of viral proteins from the nucleus
to cytoplasm at 41°C
To further investigate the inhibitory mechanism of viral
production at 41°C, the distribution of viral proteins in the
infected cells was observed in detail by immunofluorescent
staining. Infected cells were fixed at various time points
after infection, and first stained with anti-influenza virus
serum (data not shown). Viral proteins were detectable in
the nucleus but not the cytoplasm of host cells at 2 h after
infection both at 37°C and 41°C. On further culture at 37°C,
cytoplasmic fluorescence increased gradually from 4 h after
infection, showing that viral proteins once imported into the
nucleus were transferred into the cytoplasm at 37°C. On the
other hand, at 41°C, the nuclear fluorescence was stronger
than at 37°C after 4- or 6-h culture, indicating that viral
proteins remained in the nucleus. Even after 8 h, viral
proteins remained in the nucleus at 41°C. These observa-
tions suggest that the nuclear export of viral proteins into
the cytoplasm was disturbed at 41°C.
To confirm this possibility, the localizations of NP and
M1 were examined by immunofluorescent staining using
specific monoclonal antibodies. NP and M1 shuttle between
the nucleus and cytoplasm (Martin and Helenius, 1991a, b;
Whittaker et al., 1996; Neumann et al., 1997). NP is the
major component of vRNP and an indicator of vRNP-
localization. Early in the infection, NP synthesized in the
cytoplasm immediately enters the nucleus where viral RNA
(vRNA) is replicated, and encapsidates the vRNA to form
vRNP. Newly synthesized M1 also enters the nucleus to
interact with the vRNP. vRNP-M1 complexes are then
transported from the nucleus to the cytoplasm.
NP (Fig. 3A) and M1 (Fig. 3B) were already localized in
the nuclei within 2-h incubation at both temperatures, indi-
cating that these proteins were transported into the nucleus
immediately after synthesis irrespective of the temperature
(a, b in Figs. 3A and 3B, respectively). They were then
exported from the nucleus into the cytoplasm as vRNP-M1
complexes at 37°C, and as a result, all of the cell was evenly
stained after culture for 6 h and 8 h (c, e, g in Figs. 3A and
3B, respectively). However, at 41°C, they were not exported
into cytoplasm and remained in the nuclei even at 8 h after
infection (d, f, h in Figs. 3A and 3B, respectively). The
results demonstrate that the transport of NP and M1 to the
cytoplasm was inhibited at 41°C.
In addition, an unique distribution of M1 was observed at
41°C. M1 was localized at the nucleolus (arrows in Figs. 3B:
d, f, h), whereas no such distribution was seen at 37°C (arrows
in Figs. 3B: c, e, g; also compare the insets in d with c).
The presence of NP and M1 in the nucleus at 41°C was
affected by shifting the temperature to 37°C. When infected
cells cultured at 41°C were kept at 37°C, cytoplasmic NP
began to be detected weakly 1 h after the temperature shift
(Fig. 4b) and gradually increased with further incubation at
37°C (Figs. 4c, d). Similar results were obtained in M1 (data
not shown).
Effect of temperature on the cellular nuclear export
system
The results above suggest that the inhibition of viral
production at 41°C was due to a disturbance of the export of
some viral-specific proteins from the nucleus to the cyto-
Fig. 2. Synthesis of influenza virus-specific proteins at 37°C or 41°C. Total
protein was extracted from infected MDCK cells after culture for each
period of time. Viral proteins were detected by immunoblotting using
anti-influenza virus serum. Viral proteins were synthesized irrespective of
culture temperature.
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plasm. To confirm this, further investigations were per-
formed. Recently, reports have shown that influenza viral
RNP is exported from the nucleus by a cellular CRM1-
mediated nuclear export pathway (Elton et al., 2001; Ma et
al., 2001; Neumann et al., 2000). CRM1 is an essential
cellular factor for the nuclear export of proteins containing
the leucine-rich nuclear export signal (NES) (Fornerod et
al., 1997). Then, it was examined whether the cellular ex-
port system is affected at 41°C.
First, it was examined whether CRM1 is associated with
the nuclear export of influenza viral RNP in our experimen-
tal system. For this, Leptomycine B (LMB), which inhibits
CRM1 specifically (Kudo et al., 1998; Nishi et al., 1994),
was used. MDCK cells were cultured for 3 h at 37°C after
the infection to enable the accumulation of viral proteins in
the nucleus. Then, the cells were treated with LMB for
another 3 h at 37°C. NP remained predominantly in the
nucleus in the cells treated with LMB even at 37°C, indi-
cating that CRM1 is associated with the nuclear export of
influenza viral RNP (data not shown).
Thus, it was investigated whether the function of CRM1
is influenced at 41°C. MDCK cells were cultured at 41°C or
37°C for 6 h, and GFP (green fluorescent protein)-NES was
injected into the nuclei of the cells (Fig. 5 a). The cells were
incubated at 41°C or 37°C for another 30 min for nuclear
export of general NES-containing proteins and the localiza-
tion of GFP-NES was observed. GFP-NES injected into the
nucleus (Fig. 5a) was transported into the cytoplasm at 41°C
(Fig. 5g) as well as at 37°C (Fig. 5d). These results indicate
that the cellular machinery for nuclear export via CRM1 is
not impaired at 41°C.
vRNP forms even at 41°C
The formation of vRNP is required for the nuclear export
of viral proteins (Hamaguchi et al., 1985). Then, experi-
Fig. 3. Intracellular distribution of virus-specific proteins, NP and M1. Infected MDCK cells were incubated at 37°C (a, c, e, g in A and B) or 41°C (b, d,
f, h in A and B) for 2 h (a, b), 4 h (c, d), 6 h (e, f), or 8 h (g, h). The cells were indirectly immunofluorescently stained using monoclonal antibody against
NP (A) or M1 (B). At 41°C, NP and M1 continued to be detected predominantly in the nucleus even after 8-h incubation (h). M1 was also detected in the
nucleolus at 41°C (arrows in B-d, f, h), but not at 37°C (compare insets B-d with B-c). The insets in c or d are high magnification views of a nucleus. Bar,
25 m, 10 m in the insets.
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ments were conducted to determine whether vRNP formed
normally in the nucleus at 41°C. The formation of vRNP
can be detected from the separation pattern of density-
gradient centrifugation (Bui et al., 2000). Infected cells
incubated at 37°C or 41°C for 6 h were lysed and separated
into 15 fractions by glycerol-density gradient centrifuga-
tion. The position of vRNP was visualized by immunoblot-
ting using anti-NP antibody. As shown in Fig. 6A, vRNP
was sedimented in the expected position in the glycerol
gradient, peaking in fraction-11 and -12 at both tempera-
tures. The measurement of the intensity of the bands showed
that the peaks of vRNP-fractions were similar in infected
cells incubated at both 37°C and 41°C (Fig. 6B). The data
suggest that the formation of vRNP proceeds as normal
even at 41°C.
Effects of incubation temperature on the formation of
vRNP-M1 complexes
Some reports have shown that the export of vRNP into
the cytoplasm is blocked in the absence of M1 (Bui et al.,
2000; Martin and Helenius, 1991a Whittaker et al., 1996),
suggesting that the process requires M1. The interaction
between vRNP and M1 at 41°C was examined by immu-
noprecipitation assay. To investigate the association of M1
with vRNP, the extracts of infected cells were immunopre-
cipitated with anti-NP monoclonal antibody, and the pre-
cipitates were analyzed by immunoblotting using anti-influ-
enza virus serum (Fig. 7). In the infected cells cultured at
37°C, M1 was coprecipitated with NP as expected (arrow-
head in Fig. 7, Lane 2), showing that M1 associates with
vRNP. In contrast, M1 was not coprecipitated with NP in
the cells cultured at 41°C (Fig. 7, Lane 3). This indicates
that vRNP-M1 complexes were not formed at 41°C.
To understand why M1 did not associate with vRNP at
41°C, attempts were made to further characterize the M1
synthesized at 41°C. Infected cells were incubated at 41°C
or 37°C for 4 h, and cultured for another 2 h at 37°C with
cycloheximide, an inhibitor of protein translation. As the
synthesis of new viral proteins at 37°C was inhibited by
cycloheximide, viral components synthesized at 41°C could
be chased in this assay. In control cells incubated at 37°C
for the first 4 h, M1 was coprecipitated with NP (arrowheads
in Fig. 8A, Lanes 2 and 3, respectively). This shows that
cycloheximide did not affect the formation of complexes
between M1 and vRNP. On the other hand, M1 was not
coprecipitated with NP in the cells first cultured at 41°C
(Fig. 8A, Lanes 4 and 5). The results suggest that M1
synthesized at 41°C could not associate with vRNP even at
37°C.
The localization of vRNP in these cells was also ob-
served (Fig. 8B). vRNP was distributed both in the cyto-
plasm and in the nucleus (Fig. 8B-a) in control cells, in
which M1 associates with vRNP (Fig. 8A, Lane 3) even in
the presence of cycloheximide. By contrast, the export of
vRNP into the cytoplasm was inhibited (Fig. 8B-b) in the
cells first cultured at 41°C in which M1 did not associate
with vRNP (Fig. 8A, Lane 5). The results suggest that the
association of M1 with vRNP is necessary for the migration
of vRNP into the cytoplasm from the nucleus.
We further examined whether vRNP-M1 complexes
once formed at 37°C were dissolved at 41°C. Infected cells
were incubated at 37°C for 4 h to form vRNP-M1 com-
plexes and incubated for another 2 h at 41°C with cyclo-
heximide. M1 was detected in immunoprecipitates with NP
(arrowheads in Fig. 8A, Lanes 6 and 7), suggesting that the
Fig. 4. Intracellular localization of NP after shifting down the temperature
to 37°C from 41°C. Infected MDCK cells were incubated at 41°C for 4 h
(a), and then further cultured at 37°C for 1 h (b), 2 h (c), or 3 h (d). The
localization of NP was examined by immunofluorescent staining as in the
case of Fig. 3A. NP was gradually exported from the nucleus into the
cytoplasm with incubation time after the shift to 37°C. Bar, 25 m .
Fig. 5. Effect of temperature on nuclear export pathway depending on
CRM1. MDCK cells were incubated at 41°C or 37°C for 6 h and then green
fluorescence protein containing nuclear export signal (GFP-NES) was
microinjected into the nucleus (a, d, g). TRITC-BSA was coinjected as an
injection marker (b, e, h). Injected cells were fixed immediately after
injection (a-c), or after incubation for another 30 min at 37°C (d–f) or 41°C
(g–i). c, f, and i are phase-contrast images of a–b, d–e, and g-h, respec-
tively. Injected GFP-NES was exported into the cytoplasm even at 41°C
(g). Bar, 10 m.
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complex between vRNP and M1 formed at 37°C was main-
tained even at 41°C. Over this period of time, the export of
vRNP into the cytoplasm was not inhibited (Fig. 8B-c).
It was desirable, however, that these results be confirmed
without cycloheximide, because the drug may influence
indirectly the results. To chase the viral proteins, [35S]me-
thionine was used. Infected cells were incubated at 41°C or
37°C for 3 h and pulse-labeled with [35S] methionine for
another 1 h. The temperature was then shifted down to 37°C
or up to 41°C for another 2 h in normal medium and an
immunoprecipitation assay was performed similar to that in
Figs. 7 and 8. In the shift-down assay (41°C, 4 h 3 37°C,
2 h), labeled M1, which was synthesized at 41°C, was not
coprecipitated with vRNP (date not shown) consistent with
the above experiments with cycloheximide (Fig. 8A, Lanes
4 and 5). However, in the shift-up assay (37°C, 4 h3 41°C,
2 h), it was found unexpectedly that the vRNP-M1 com-
plexes once formed at 37°C dissociated gradually at 41°C
(Fig. 9, Lanes 5 and 6). This was in contradiction to the
above results with cycloheximide (Fig. 8A, Lanes 6 and 7).
Since the results obtained without the drug more reasonably
reflected the normal state of cells, it is considered that the
complexes between vRNP and M1 were dissociated at
41°C, and that cycloheximide inhibited the dissociation at
41°C (see Discussion).
Discussion
Viral production has been found to be suppressed at
41°C in many kinds of virus (Ishida et al., 2002). Production
of the influenza virus was also inhibited at 41°C. In this
study, we showed that the suppression of influenza viral
production was due to a disturbance of the nuclear export of
Fig. 6. Segmentation of vRNP by glycerol-density gradient centrifugation. Infected MDCK cells were incubated at 37°C or 41°C for 6 h, and lysed as
described in Materials and methods. The extracts were layered onto a step-glycerol gradient, and separated into 15 fractions. vRNP was detected by
immunoblotting with anti-NP antibody (A). The intensity of the bands of NP was measured by NIH image (B). The peaks of vRNP were at fraction-11 and
-12 at both temperatures, suggesting that the formation of vRNP was not impaired at 41°C.
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viral proteins. There are no reports that the nuclear export of
influenza viral proteins is temperature-sensitive, although
some studies report that viral production is influenced at
high temperature (Scholtissek and Rott, 1969; Kendal et al.,
1977; Oxford et al., 1980; Chu et al., 1982; Giesendorf et
al., 1984). Further investigation significantly demonstrated
that M1 did not associate with vRNP at 41°C and this
dissociation caused the viral proteins to remain in the nu-
cleus at 41°C. M1 is reported to be required for nuclear
export of vRNP in the influenza virus. When a M1-defective
virus is used or the synthesis of M1 is inhibited, the export
of vRNP from the nucleus fails to occur (Martin and Hele-
nius, 1991a; Bui et al., 2000). Microinjection of antibodies
against M1 blocks the process of vRNP-export (Martin and
Helenius, 1991a). On the other hand, electron microscopic
observation and in vitro binding assay suggest that M1
interacts with vRNP, especially with viral RNA (Martin and
Helenius, 1991a; Ye et al., 1999). Thus, it is conceivable
that the association of M1 is necessary for nuclear export of
vRNP (Martin and Helenius, 1991a; Bui et al., 2000). How-
ever, no direct proof had been obtained. Our results directly
indicate that the binding of M1 with vRNP is closely related
to their migration from the nucleus. This is the first report
showing that the formation of a complex of M1 and vRNP
is essential for their nuclear export into the cytoplasm.
NEP/NS2, a small component protein of the influenza virus,
is also reported to mediate the export of vRNP from the
nucleus by acting as an adaptor protein between CRM1, a
nuclear export machinery, and the M1-vRNP complex
(O’Neill et al., 1998; Neumann et al., 2000). Further inves-
tigating the function of NEP/NS2 at 41°C would provide a
more accurate model of the nuclear export of influenza viral
proteins. An investigation is in progress.
M1 was uniquely distributed in the nucleolus at 41°C.
Concerning this, there is a report that M1 is localized in the
nucleolus when it alone is expressed in CV-1 cells (Bucher
Fig. 8. Interaction of M1 synthesized at 41°C or 37°C with vRNP. (A)
Infected cells were incubated at 37°C or 41°C for 4 h, and then further
cultured at 37°C or 41°C for 2 h with 50 M cycloheximide (CHX). The
interaction between vRNP and M1 was examined by immunoprecipitation
using anti-NP antibody similar to in Fig. 7. Lane 1; markers of viral
proteins, Lanes 2 and 3; precipitates from infected cells incubated at 37°C
for 4 h and incubated another 1 h (Lane 2) or 2 h (Lane 3) at 37°C with
cycloheximide, Lanes 4 and 5; precipitates from infected cells incubated at
41°C for 4 h and another 1 h (Lane 4) or 2 h (Lane 5) at 37°C with
cycloheximide, Lanes 6 and 7; precipitates from infected cells incubated at
37°C for 4 h and another 1 h (Lane 6) or 2 h (Lane 7) at 41°C with
cycloheximide. (B) Fluorescent images of NP in the cells shown in Lane 3,
5, or 7 in (A). Namely, infected cells were incubated at 37°C (a, c) or 41°C
(b) for 4 h and incubated for another 2 h at 37°C (a, b) or 41°C (c) with
cycloheximide. The binding of M1 with vRNP is associated with the
migration of vRNP from the nucleus to cytoplasm. Bar, 25 m.
Fig. 7. Interaction of M1 with vRNP in infected cells. Infected cells were
incubated at 37°C or 41°C for 4 h and total protein was extracted as
described in Materials and methods. Cell lysates were immunoprecipitated
with anti-NP antibody and immunoblotted using anti-influenza virus se-
rum. Lane 1; markers of viral proteins, Lane 2; precipitates from infected
cells incubated at 37°C, Lane 3; precipitates from infected cells incubated
at 41°C. M1 was not coimmunoprecipitated with vRNP at 41°C.
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et al., 1989). Consistent with this report and our observa-
tion, M1 does not associate with vRNP. M1 may tend to be
localized in the nucleolus when it exists alone, but is trans-
ferred into the cytoplasm when it forms a complex with
vRNP in the nucleus.
The shift-down assay with cycloheximide and [35S]me-
thionine suggested that M1 synthesized at 41°C could not
associate with vRNP even at 37°C. However, the results
were reversed in the shift-up assay using cycloheximide and
[35S]methionine. In the presence of cycloheximide, the M1-
vRNP complex that formed at 37°C appeared even at 41°C.
However, M1 labeled at 37°C was separate from vRNP at
41°C, suggesting that the complex was dissociated at 41°C.
As described in the “Results”, the behavior of labeled pro-
teins reflects the natural state in the cell. From the results, it
is considered that cycloheximide is associated with the
inhibition of the dissociation of the M1-vRNP complex at
41°C. Namely, certain proteins synthesized only at 41°C,
such as heat shock proteins, obstruct the association of M1
with vRNP. As such proteins are not synthesized in the
presence of cycloheximide, the M1-vRNP complex does not
dissociate even at 41°C. Cellular phosphorylation events are
reported to affect the nuclear export of vRNP (Bui et al.,
2000, 2002; Pleschka et al., 2001). In our experimental
system, however, M1 synthesized at 41°C did not bind with
vRNP when the cells were then cultured at 37°C, suggesting
that the change to vRNP or M1 at 41°C is irreversible. This
implies another mechanism to prevent the nuclear export of
vRNP at 41°C, other than phosphorylation. If phosphoryla-
tion is simply involved, the association between M1 syn-
thesized at 41°C and vRNP will be recovered by shifting
down to 37°C, at which temperature the cellular phosphor-
ylation system is normal. We assume that the obstructive
proteins induce irreversible, perhaps conformational,
changes in vRNP or M1 at 41°C. Identifying such obstruc-
tive factors will provide important information not only on
the mechanism of nuclear export of viral proteins, but also
on how to inhibit influenza viral infection.
Materials and methods
Cells and virus
MDCK cells, derived from canine kidney, were grown in
minimum essential medium (MEM) supplemented with
10% calf serum (CS) as described previously (Kim et al.,
1990). When indicated, the cells were treated with 10 ng/ml
of Leptomycine B (a gift from Dr. Minoru Yoshida, Tokyo
University, Tokyo, Japan) or 50 M cycloheximide (Sigma
Chemical Co., CA).
Influenza A virus (A/Aichi/2/68/H3N2) (kindly provided
by Dr. Yosinobu Okuno, Osaka Prefectural Institute of
Public Health, Osaka, Japan) was propagated in chick em-
bryonated eggs as described previously (Yamaoka et al.,
1995). The harvested infectious chorioallantoic fluid was
stored at 80°C until use.
Viral infection
Viral infection was carried out as described previously
(Yamaoka et al., 1995). Briefly, 1  106 MDCK cells were
seeded into a 35-mm diameter dish and incubated at 37°C
for 48 h in 10% CS-MEM. The cells were washed once with
PBS (phosphate-buffered saline; 8 g/l NaCl, 0.2 g/l KCl, 2.9
g/l Na2HPO412H2O, 0.2 g/l KH2PO4) containing 2 mM
CaCl2 (PBS()) and 0.2 ml of infectious chorioallantoic
fluid diluted with PBS() was inoculated onto MDCK
monolayers at a multiplicity of infection (m.o.i.) of 2  103
(2  103 virions per cell) at 4°C for 60 min with occasional
tilting. Infected cells were washed twice with PBS and
cultured in 1 ml of Dulbecco’s modified Eagle’s medium
(DMEM) with 10% CS. To measure the viral production in
host cells, 0.05 ml of culture fluid was harvested at various
time points after the infection and hemagglutinating activity
(HA) was measured using 0.5% (v/v) chick red blood cells
in PBS as described previously (Salk, 1944).
Antibodies
Anti-influenza virus polyclonal antibodies were prepared
by immunizing rabbits with purified influenza virus from
infectious chorioallantoic fluid. Monoclonal antibodies
against NP or M1 of the influenza virus were prepared by a
method described previously (Hyodo and Kim, 1994).
Fig. 9. Effect of incubation temperature on the association of M1 with
vRNP. Infected cells were incubated at 37°C for 3 h and labeled with
[35S]methionine for 1 h. Labeled cells were then incubated for another 2 h
at 37°C or 41°C in normal medium. Cells were lysed and immuno-
precipitated using anti-NP antibody similar to in Fig. 7 or 8. The associ-
ation between vRNP and M1 was detected from the radioactivity of M1.
Lane 1; markers of viral proteins, Lane 2; precipitates from infected cells
incubated at 37°C for 3 h and labeled for 1 h, Lanes 3 and 4; precipitates
from infected cells incubated for another 1 h (Lane 3) or 2 h (Lane 4) at
37°C after labeling, Lanes 5 and 6; precipitates from infected cells shifted
up to 41°C for 1 h (Lane 5) or 2 h (Lane 6) after labeling. M1 was
dissociated from vRNP by shift up to 41°C (Lanes 5 and 6).
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Briefly, viral proteins extracted from purified virus with
0.5% sodium dodecyl sulfate (SDS) were injected into
4-week-old female Balb/c mice. Spleen cells were fused
with myeloma cells (X63-Ag8-6.5.3.) by polyethylene gly-
col-4000 (Nacalai Tesque, Kyoto, Japan). Hybridoma cells
producing antibodies to NP or M1 were cloned by limited
dilution. Monoclonal antibodies were purified from the cul-
ture supernatant of hybridoma cells.
SDS–PAGE and immunoblotting
All procedures were performed as described previously
(Laemmli, 1970; Saiuchi et al., 1993). Briefly, SDS-extracts of
infected cells were separated in 11% or 13% polyacrylamide
gels, and transferred onto nitrocellulose membranes. The blot-
ted membranes were incubated in Tris-buffered saline (2.42 g/l
Tris-(methyl hydroxy)-aminomethane, 29.24 g/l NaCl, pH ad-
justed to 7.5 with HCl) containing 4% skim milk to block the
nonspecific absorption of antibodies. The membranes were
reacted with anti-influenza virus serum and viral proteins on
the membranes were visualized with horseradish peroxidase
(HRP)-conjugated goat anti-rabbit IgG (Bio-Rad Laboratories,
CA) and 4-chloro-1-naphthol.
Pulse-labeling
Infected MDCK cells were labeled with 50 Ci/ml
[35S]methionine (American Radiolabeled Chemicals, Inc.,
MO) in DMEM deficient in methionine (GIBCO BRL, NY)
from 5 to 6 h after infection. Total protein was extracted
from infected cells as described previously (Saiuchi et al.,
1993) and separated on 13% SDS-polyacrylamide gel. The
gel was dried and exposed to a Fuji Imaging Plate Type
BAS-III (Fuji Film Co. Ltd., Tokyo, Japan) for 6 h. Radio-
active viral proteins were analyzed with a Bio-Imaging
Analyzer BAS-2000II system (Fuji Film Co.).
Indirect immunofluorescent staining
Indirect immunofluorescent staining was performed as
described previously (Kim et al., 1995). The cells grown on
glass coverslips were fixed in a mixture of acetone and
methanol (1:1), subjected to antibody-treatment with anti-
influenza virus serum, anti-NP monoclonal antibody, or
anti-M1 monoclonal antibody, and counterstained with flu-
orescein isothiocyanate (FITC)-conjugated anti-rabbit or
mouse immunoglobulin goat antibodies (Cappel/ICN Phar-
maceuticals, Inc., OH).
Microinjection assay
MDCK cells were seeded on glass coverslips and cultured
for 48 h at 37°C. The cells were further incubated for 6 h at
41°C or 37°C as a control. Green fluorescence protein (GFP)
fused with nuclear export signal of protein kinase inhibitor
(GFP-NES) (a gift from Dr. Yoshihiro Yoneda, Osaka Uni-
versity, Osaka, Japan) (Tachibana et al., 1996) was microin-
jected through a glass capillary into the nuclei of cells with
TRITC-BSA (Sigma Chemical Co.), which enables one to
monitor the actual site of injection. Injected cells were then
incubated for 30 min at 41°C or 37°C. After fixation for 10 min
with 3.7% formaldehyde in PBS at room temperature, the
localization of injected proteins was observed by fluorescent
microscopy (Carl Zeiss, Oberkochen, Germany).
Glycerol-density gradient centrifugation
Glycerol-density gradient centrifugation was performed ac-
cording to the method of Bui et al. (2000). The cells incubated
at 37°C or 41°C for 6 h after viral infection were scraped and
lysed into PBS containing 0.1% Triton X-100. The cell lysate
was treated with DNase I (50 g/ml) for 30 min at 37°C,
followed by the addition of NaCl to a final concentration of 1
M. The mixture was centrifuged, and the supernatants were
loaded onto a step glycerol-gradient (1 ml of 70%, 0.75 ml of
50%, 0.375 ml of 40%, and 1.8 ml of 33% [wt/vol] glycerol).
The gradient was centrifuged at 45000 rpm for 4 h at 4°C in a
SW50.1 rotor (Beckman, CA). Fractions were collected from
the bottom and concentrated. Each fraction was analyzed by
SDS–PAGE and immunoblotting using anti-NP monoclonal
antibody. The intensity of the bands of NP was measured by
NIH Image, an image processing and analysis program for the
Macintosh computer provided free by the National Institutes of
Health (MD, USA).
Immunoprecipitation assay
Infected cells incubated for 4 h at 37°C or 41°C were
harvested in TNE buffer (10 mM Tris–HCl, pH 7.8, 1% NP-
40, 150 mM NaCl, 1 mM EDTA, and 25g/ml aprotinin), and
lysed by 20–30 strokes through a 27 gauge needle until the
nuclear membrane was almost disrupted for monitoring by
microscopy. After centrifugation at 12000 rpm for 15 min at
4°C in a TMA-4 rotor (TOMY SEIKO, Co. Ltd., Tokyo,
Japan), the cell lysate was treated with anti-NP monoclonal
antibody (9 g/ml) and incubated for 4 h at 4°C. Then 2.5%
[v/v] protein A-Sepharose CL-4B (Amersham Pharmacia Bio-
tech AB, Uppsala, Sweden) was added to the antibody-cell
extract mixture and incubated for 2 h at 4°C with gentle
shaking. Immunoprecipitates bound to the Sepharose beads
were pelleted by centrifugation at 2000 rpm in a TMA-4 rotor
and washed 6 times with TNE buffer. Immunoprecipitates
were then suspended in SDS sample buffer (Hyodo and Kim,
1994) containing 0.125 M DTT and boiled for 3 min. The
samples were analyzed by 11% SDS–PAGE followed by im-
munoblotting using anti-influenza virus serum.
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